EDGAR Filing Documents for 0001437749-23-022773

Form 8-K - Current report:

SEC Accession No. 0001437749-23-022773

Filing Date

2023-08-09

Accepted

2023-08-09 16:02:01

Documents

Period of Report

2023-08-08

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	dffn20230808_8k.htm iXBRL	8-K	45222
2	EXHIBIT 99.1	ex_557527.htm	EX-99.1	232793
3	EXHIBIT 99.2	ex_557528.htm	EX-99.2	436418
4	EXHIBIT 99.3	ex_556936.htm	EX-99.3	13287
9		invpres_page01.jpg	GRAPHIC	84395
10		invpres_page02.jpg	GRAPHIC	241288
11		invpres_page03.jpg	GRAPHIC	275484
12		invpres_page04.jpg	GRAPHIC	127113
13		invpres_page05.jpg	GRAPHIC	152751
14		invpres_page06.jpg	GRAPHIC	101670
15		invpres_page07.jpg	GRAPHIC	132926
16		invpres_page08.jpg	GRAPHIC	144913
17		invpres_page09.jpg	GRAPHIC	148171
18		invpres_page10.jpg	GRAPHIC	176444
19		invpres_page11.jpg	GRAPHIC	137334
20		invpres_page12.jpg	GRAPHIC	131405
21		invpres_page13.jpg	GRAPHIC	152050
22		invpres_page14.jpg	GRAPHIC	117087
23		invpres_page15.jpg	GRAPHIC	102986
24		invpres_page16.jpg	GRAPHIC	148261
25		invpres_page17.jpg	GRAPHIC	108351
26		invpres_page18.jpg	GRAPHIC	101912
27		invpres_page19.jpg	GRAPHIC	68945
28		invpres_page20.jpg	GRAPHIC	82918
	Complete submission text file	0001437749-23-022773.txt		4697667

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA	dffn-20230808.xsd	EX-101.SCH	3408
6	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	dffn-20230808_def.xml	EX-101.DEF	11423
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	dffn-20230808_lab.xml	EX-101.LAB	15309
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	dffn-20230808_pre.xml	EX-101.PRE	11583
30	EXTRACTED XBRL INSTANCE DOCUMENT	dffn20230808_8k_htm.xml	XML	2575

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902

Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718

Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)